{"meta":{"query_hash":"c86d86eb121f","filters":{"venue":"Journal of Experimental Therapeutics and Oncology"},"cohort_total":6,"direct_labels_cover":0,"predictions_cover":6,"exported":6,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/c86d86eb121f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Experimental+Therapeutics+and+Oncology"},"results":[{"id":"W1975200147","doi":"10.1111/j.1533-869x.2003.01099.x","title":"Combining doxorubicin and liposomal anti‐HER‐2/NEU antisense oligodeoxynucleotides to treat HER‐2/NEU‐expressing MDA‐MB‐435 breast tumor model","year":2003,"lang":"en","type":"article","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada); University of British Columbia","funders":"","keywords":"HER2/neu; Liposome; Doxorubicin; Cancer research; Pharmacology; Breast tumor; Medicine; Biology; Breast cancer; Internal medicine; Chemotherapy; Cancer; Biochemistry","score_opus":0.04966820151808032,"score_gpt":0.36803817291482427,"score_spread":0.31836997139674394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975200147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909763,0.0025584898,0.0050753215,0.00010229383,0.00009975528,0.00012766829,0.00013127124,0.00006837907,0.00086061173],"genre_scores_gemma":[0.98924667,0.0025609073,0.0053258184,0.000057333076,0.00002947285,0.00011947997,0.00021882958,0.000015779517,0.0024257388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999182,0.000012099153,0.000006463998,0.00002212804,0.000019824933,0.00002128256],"domain_scores_gemma":[0.9999641,0.000006019378,0.000008708512,0.0000033141314,0.000005707572,0.000012160266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016409766,0.00038393636,0.00044259362,0.00018135687,0.00007278163,0.00018741461,0.00016459425,0.0002639196,0.00043498675],"category_scores_gemma":[0.0000662379,0.00013538865,0.0001861599,0.00010919212,0.00011414328,0.00021021556,0.00012311344,0.00037765593,0.00013911272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013560671,0.00008558768,0.00007425314,0.000044348344,0.000008126878,0.000021136268,0.000009734451,0.00013344207,0.9974584,0.000045423727,0.00002853596,0.0019555888],"study_design_scores_gemma":[0.000090893074,0.0049095424,0.0014025292,0.000008543897,0.00007125508,0.00016167187,0.00001566697,0.0017734399,0.98827666,0.000029948897,0.0032490268,0.000010754328],"about_ca_topic_score_codex":0.00081009045,"about_ca_topic_score_gemma":0.0019317231,"teacher_disagreement_score":0.00081009045,"about_ca_system_score_codex":0.00020377718,"about_ca_system_score_gemma":0.0002486835,"threshold_uncertainty_score":0.0016107559},"labels":[],"label_agreement":null},{"id":"W2071404901","doi":"10.1046/j.1359-4117.2003.01063.x","title":"Superinduction of P‐glycoprotein messenger RNA in vivo in the presence of transcriptional inhibitors","year":2003,"lang":"en","type":"article","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Northern British Columbia","funders":"National Cancer Institute","keywords":"In vivo; Chemistry; Messenger RNA; Five-prime cap; RNA; P-glycoprotein; Glycoprotein; Biochemistry; Cell biology; Molecular biology; Biology; Gene; Genetics; Antibiotics; RNA editing; Multiple drug resistance","score_opus":0.03270574526117896,"score_gpt":0.31640243558227077,"score_spread":0.2836966903210918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071404901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745443,0.0039338134,0.016274817,0.00030531376,0.00024742068,0.0002301618,0.001032756,0.00044627412,0.0029850868],"genre_scores_gemma":[0.9629407,0.0033126266,0.019165318,0.00029081586,0.00018837824,0.0005234283,0.0038715403,0.00025019972,0.00945699],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948823,0.00013067608,0.00004424226,0.0001242741,0.00011442632,0.00009817942],"domain_scores_gemma":[0.9989335,0.0005520115,0.00017071955,0.00013658566,0.00007648415,0.00013068566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005588527,0.00060227374,0.00042816825,0.00043728168,0.00013410124,0.00040963327,0.00036188457,0.0003585272,0.0017810939],"category_scores_gemma":[0.00042362337,0.00031253774,0.00048447028,0.00033295166,0.00047762113,0.00023225816,0.00026879326,0.0014088202,0.0005786965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014530256,0.000043448123,0.00002969739,0.00001726718,0.0000032496898,0.000011143427,0.000012882569,0.00004281844,0.99918646,0.00004826936,0.000022431801,0.000436987],"study_design_scores_gemma":[0.000021994952,0.00090225716,0.0006549831,0.0000047260132,0.0000124149,0.000030056915,0.0000100588795,0.00080598425,0.9965115,0.000036589572,0.0010047836,0.000004604193],"about_ca_topic_score_codex":0.0004646334,"about_ca_topic_score_gemma":0.0010063981,"teacher_disagreement_score":0.0017810939,"about_ca_system_score_codex":0.00041220593,"about_ca_system_score_gemma":0.00037261052,"threshold_uncertainty_score":0.0059583783},"labels":[],"label_agreement":null},{"id":"W2111254733","doi":"10.1046/j.1359-4117.2003.01075.x","title":"Combined treatment of Bcl‐2 antisense oligodeoxynucleotides (G3139), p‐glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug‐resistant growth of drug‐resistant breast cancer in severely combined immunodeficient mice","year":2003,"lang":"en","type":"article","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada); University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Drug; Doxorubicin; Liposome; P-glycoprotein; Chemistry; Drug resistance; Breast cancer; Pharmacology; Cancer research; Cancer; Multiple drug resistance; Chemotherapy; Medicine; Biochemistry; Biology; Internal medicine; Microbiology; Antibiotics","score_opus":0.013757663765126956,"score_gpt":0.27694928168881405,"score_spread":0.2631916179236871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111254733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980173,0.00053030887,0.00062174414,0.000058960162,0.000027120133,0.000034123328,0.000121830184,0.00007408644,0.0005145376],"genre_scores_gemma":[0.99698645,0.00052453054,0.001207452,0.000045158853,0.000014173201,0.00004722152,0.00022771022,0.000010599223,0.00093672663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998623,0.000022071143,0.000013855622,0.000029783529,0.000034045628,0.000037936807],"domain_scores_gemma":[0.99991786,0.00001189791,0.000022401919,0.000010784105,0.0000062326353,0.00003087785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012428057,0.00041812734,0.00039416715,0.0002606162,0.000107949774,0.00016950529,0.00021714177,0.00028564263,0.0006376283],"category_scores_gemma":[0.00008223804,0.00016725373,0.00020405483,0.00016244913,0.0002063788,0.00017398653,0.00013779383,0.0006239575,0.00021432951],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024077512,0.00010524576,0.00010204612,0.000017603063,0.000005754336,0.000028798038,0.000008713143,0.00007774225,0.99820185,0.00003970269,0.000031492713,0.0011403691],"study_design_scores_gemma":[0.00011025812,0.0020905833,0.0015586182,0.0000028370728,0.000025768497,0.00014389411,0.000007132597,0.0008190348,0.9944155,0.000021650652,0.0008002393,0.000004503718],"about_ca_topic_score_codex":0.0005653743,"about_ca_topic_score_gemma":0.0013544997,"teacher_disagreement_score":0.0006376283,"about_ca_system_score_codex":0.00019042693,"about_ca_system_score_gemma":0.0002745884,"threshold_uncertainty_score":0.0021330714},"labels":[],"label_agreement":null},{"id":"W2122355107","doi":"10.1046/j.1359-4117.2002.1009x.x","title":"Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P‐glycoprotein","year":2002,"lang":"en","type":"article","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"P-glycoprotein; Intracellular; Multiple drug resistance; Cytotoxicity; Verapamil; Chemistry; Pharmacology; In vitro; Biochemistry; Biology","score_opus":0.038035442861318526,"score_gpt":0.3178484084531365,"score_spread":0.27981296559181795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122355107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916966,0.002261758,0.0064525143,0.00012606347,0.000016508813,0.000055641052,0.00019041917,0.00008876519,0.0016387053],"genre_scores_gemma":[0.99290353,0.00088316086,0.0043665506,0.00003766674,0.000013015675,0.0000593143,0.00022802554,0.000022256996,0.0014863844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999858,0.00002666332,0.000014079729,0.00003131309,0.000032570155,0.00003731869],"domain_scores_gemma":[0.9998198,0.00004860845,0.00005827248,0.000019118741,0.00002486845,0.000029324783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014149336,0.0006007038,0.0005627193,0.00025494152,0.00019065494,0.00053461187,0.0002694463,0.0005428394,0.0015191183],"category_scores_gemma":[0.00021134182,0.00028212927,0.00034357354,0.00015456014,0.00030408986,0.0007256123,0.00028993355,0.0005827947,0.0006013483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011067294,0.000020499787,0.00021067128,0.000030125491,0.00000168958,0.00016365528,0.000025443827,0.000034319324,0.9983576,0.00012749448,0.000011228372,0.00090663775],"study_design_scores_gemma":[0.000046431378,0.00046697646,0.011719809,0.0000070639658,0.000016665681,0.0011800069,0.000070828166,0.0015137759,0.9837112,0.00021992755,0.0010358839,0.000011533185],"about_ca_topic_score_codex":0.000247422,"about_ca_topic_score_gemma":0.00022193212,"teacher_disagreement_score":0.0015191183,"about_ca_system_score_codex":0.00032820858,"about_ca_system_score_gemma":0.00012450237,"threshold_uncertainty_score":0.0050819516},"labels":[],"label_agreement":null},{"id":"W2150577846","doi":"10.1046/j.1359-4117.2003.01067.x","title":"The reversal of multidrug resistance: an update","year":2003,"lang":"en","type":"review","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Citation; Library science; Resistance (ecology); Computer science; Biology","score_opus":0.06783562721478266,"score_gpt":0.41316658898475334,"score_spread":0.3453309617699707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150577846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012551135,0.9974929,0.00021681121,0.0005496561,0.000984054,0.000007487155,0.000022769851,0.000013909907,0.0005869773],"genre_scores_gemma":[0.0005082853,0.99727803,0.00036614767,0.00059993577,0.000701118,0.000008982042,0.000043491124,0.000002633578,0.00049126695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996474,0.000059422437,0.00007467892,0.000060776394,0.0001205054,0.00003725575],"domain_scores_gemma":[0.9988269,0.0005756617,0.00012269923,0.000038396865,0.00031702986,0.000119313605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016176006,0.0016747446,0.0033883934,0.0030875644,0.00041859972,0.0023626497,0.0019825802,0.0024186852,0.0039026388],"category_scores_gemma":[0.0018745655,0.00058609294,0.0008704487,0.003102272,0.0010048705,0.0034093813,0.0009212857,0.003667721,0.002734209],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027869575,0.00020284406,0.00022185282,0.013464091,0.00013726765,0.0004471307,0.00005891389,0.00033540095,0.0017305579,0.0019563811,0.069440216,0.91172665],"study_design_scores_gemma":[0.00012775419,0.00028241728,0.00065893907,0.0022367558,0.00026271294,0.0018688866,0.000052674837,0.00014575898,0.00046353153,0.00095536443,0.99291575,0.00002944661],"about_ca_topic_score_codex":0.0013212507,"about_ca_topic_score_gemma":0.003072887,"teacher_disagreement_score":0.0039026388,"about_ca_system_score_codex":0.00090674066,"about_ca_system_score_gemma":0.0015683434,"threshold_uncertainty_score":0.013055623},"labels":[],"label_agreement":null},{"id":"W2153203656","doi":"10.1046/j.1359-4117.2002.01061.x","title":"Gene therapy in cancer","year":2002,"lang":"en","type":"review","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Gene; Genetics; Cancer; Genetic enhancement; Biology; Bioinformatics; Biotechnology","score_opus":0.13880478917218347,"score_gpt":0.46112775288835706,"score_spread":0.3223229637161736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153203656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011990332,0.9938346,0.00031153575,0.0007380836,0.0007891376,0.000010119579,0.000006900966,0.000011910958,0.0041778754],"genre_scores_gemma":[0.0013052209,0.9920664,0.00048471306,0.00091329205,0.0004825536,0.000018609642,0.000019362818,0.000004100897,0.0047057443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996549,0.00009217685,0.000022950322,0.00005351817,0.00014638374,0.00003002209],"domain_scores_gemma":[0.9997185,0.00013042042,0.000023574694,0.00002086659,0.000074733696,0.000031938904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008842587,0.0009773117,0.0012395427,0.0019982213,0.0006697062,0.0013408043,0.0008836165,0.0023681982,0.005768617],"category_scores_gemma":[0.0006701819,0.00022912539,0.00041822257,0.0024292124,0.0014885454,0.0019333657,0.00095267955,0.003060916,0.004761674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006772294,0.00011030112,0.00017126005,0.004854886,0.000038078862,0.00044549178,0.00016710244,0.0005426468,0.0032671047,0.022503864,0.07868227,0.8891493],"study_design_scores_gemma":[0.000016581162,0.000053968994,0.0002093112,0.00082737464,0.0000125336055,0.0012306491,0.00003983696,0.00005681229,0.00048024164,0.0046292157,0.9924346,0.000008972292],"about_ca_topic_score_codex":0.0012641196,"about_ca_topic_score_gemma":0.0024132426,"teacher_disagreement_score":0.005768617,"about_ca_system_score_codex":0.0013222289,"about_ca_system_score_gemma":0.0010663774,"threshold_uncertainty_score":0.019297957},"labels":[],"label_agreement":null}]}